Negative Association of c-fos Expression as a Favorable Prognostic Indicator in Gastric Cancer

Archives of Medical Research

Volumn 41, Issue 3, 2010, Pages 201-206

  Zhou, Li ^a   Zhang, Jie Shi ^a   Yu, Jian Chun ^a   Cui, Quan Cai ^a   Zhou, Wei Xun ^a   Kang, Wei Ming ^a   Ma, Zhi Qiang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

C fos; Gastric cancer; Immunohistochemistry; Resection; Survival

Indexed keywords

PROTEIN C FOS;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHINESE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-FOS; STOMACH NEOPLASMS;

EID: 77953521301     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.04.009     Document Type: Article

References (31)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Shields J.M., Pruitt K., McFall A., et al. Understanding Ras: " it ain't over 'til it's over" Trends Cell Biol 2000, 10:147-154.
3. Nesbit C.E., Tersak J.M., Prochownik E.V. Myc oncogenes and human neoplastic disease. Oncogene 1999, 18:3004-3016.
4. Chiu R., Boyle W.J., Meek J., et al. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988, 54:541-552.
5. Curran T., Franza B.R. Fos and Jun: the AP-1 connection. Cell 1988, 55:395-397.
6. Semba K., Kamata N., Toyoshima K., et al. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 1985, 82:6497-6501.
7. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 2005, 41:2449-2461.
8. Volm M., Drings P., Wodrich W. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol 1993, 119:507-510.
9. Bland K.I., Konstadoulakis M.M., Vezeridis M.P., et al. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 1995, 221:706-718.
10. Gamberi G., Benassi M.S., Bohling T., et al. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 1998, 55:556-563.
11. Singh A., Tong A., Ognoskie N., et al. Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression. Am J Clin Oncol 1998, 21:466-469.
12. Mahner S., Baasch C., Schwarz J., et al. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br J Cancer 2008, 99:1269-1275.
13. Mitsuno Y., Maeda S., Yoshida H., et al. Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. Biochem Biophys Res Commun 2002, 291:868-874.
14. Chang Y.J., Wu M.S., Lin J.T., et al. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005, 175:8242-8252.
15. Wu J.Y., Lu H., Sun Y., et al. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res 2006, 66:5111-5120.
16. Chen Y.C., Wang Y., Li J.Y., et al. H. pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade. World J Gastroenterol 2006, 12:5972-5977.
17. Ashktorab H., Daremipouran M., Wilson M., et al. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol 2007, 102:2135-2146.
18. Takeuchi K., Motoda Y., Ito F. Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent. FEBS J 2006, 273:3743-3755.
19. Shin V.Y., Wu W.K., Chu K.M., et al. Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol Sci 2007, 96:21-29.
20. Jin S.P., Kim J.H., Kim M.A., et al. Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathol Oncol Res 2007, 13:284-289.
21. Sobin L.H., Wittekind C.H. TNM Classification of Malignant Tumors 2002, Wiley-Liss, New York, pp. 65-68. 6th ed.
22. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
23. Carneiro F., Oliveira C., Leite M., et al. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol 2008, 25:274-287.
24. Donati V., Faviana P., Dell'omodarme M., et al. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer. Hum Pathol 2004, 35:1347-1352.
25. Linderoth J., Ehinger M., Akerman M., et al. Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma. Eur J Haematol 2007, 79:146-149.
26. Chen J.P., Chen L., Leek J., et al. Antisense c-myc fragments induce normal differentiation cycles in HL-60 cells. Eur J Clin Invest 2006, 36:49-57.
27. Zhang X., Zhang L., Yang H., et al. c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells. Cancer Res 2007, 67:9425-9434.
28. Allam M., Julien N., Zacharie B., et al. Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393. Clin Immunol 2007, 125:318-327.
29. Li-Weber M., Treiber M.K., Giaisi M., et al. Ultraviolet irradiation suppresses T cell activation via blocking TCR-mediated ERK and NF-kappa B signaling pathways. J Immunol 2005, 175:2132-2143.
30. Mann J., Oakley F., Johnson P.W., et al. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1. J Biol Chem 2002, 277:17125-17138.
31. Fukuda K., Tsujitani S., Maeta Y., et al. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer 2002, 5:220-227.